Grading Severity of Pancreatitis

Clinical Scoring Systems

• The American College of Surgeons recommends using the Bedside Index of Severity in Acute Pancreatitis (BISAP) score to grade pancreatitis severity due to its simplicity and accuracy in predicting severity, mortality, and organ failure comparable to more complex scoring systems 1, 2
• BISAP evaluates five parameters within 24 hours of admission: Blood urea nitrogen >25 mg/dl, Impaired mental status, Systemic inflammatory response syndrome (SIRS), Age >60 years, and Pleural effusion on radiography 1, 2
• The BISAP score is similar in accuracy to the APACHE-II score but is much simpler to calculate at the bedside 1, 3
• APACHE-II score of ≥8 indicates severe acute pancreatitis, with a score of ≥6 having 95% sensitivity for detecting complications but only 50% positive predictive value 4, 5
• APACHE-II can be used for ongoing daily assessment to monitor disease progression or recovery 4

Laboratory Markers

• C-reactive protein (CRP) is a valuable prognostic indicator, with peak levels >210 mg/l in the first four days (or >120 mg/l at the end of the first week) indicating severe disease with 80% accuracy 4
• CRP ≥150 mg/l on day 3 can be used as a prognostic factor for severe acute pancreatitis 6
• Hematocrit >44% is an independent risk factor for pancreatic necrosis 6
• Blood urea nitrogen (BUN) >20 mg/dl is an independent predictor of mortality 6
• Procalcitonin is highly sensitive for detecting pancreatic infection, with low values being strong negative predictors of infected necrosis 6

Radiological Assessment

• Dynamic contrast-enhanced CT scan should be performed in all severe cases between 3-10 days after admission 4
• The CT Severity Index (CTSI) combines assessment of pancreatic inflammation and necrosis, with scoring ranges from 0-10 based on pancreatic inflammation grade and extent of pancreatic necrosis 6
• CTSI correlates with morbidity and mortality, with scores of 0-1 indicating minimal morbidity and mortality, and scores of 7-10 indicating 92% morbidity and 17% mortality 6

Organ Failure Assessment

• The presence of organ failure (pulmonary, circulatory, or renal insufficiency) clinically indicates a severe attack according to the Atlanta definitions 4, 5

Practical Approach to Severity Grading

• Calculate BISAP score within the first 24 hours of admission 1, 2
• Measure CRP levels (ideally on day 3) 4, 6
• Perform contrast-enhanced CT scan between days 3-10 in patients with predicted severe disease 4
• Monitor for development of organ failure 4, 5

Severity Assessment in Acute Pancreatitis

Primary Recommended Scoring System

• A BISAP score ≥2 is the critical cutoff indicating severe acute pancreatitis, organ failure risk, and increased mortality, with the BISAP score demonstrating an area under the curve (AUC) of 0.80 for predicting severe pancreatitis and 0.93 for organ failure 7

Alternative Scoring Systems

• The APACHE-II score remains highly accurate but is more cumbersome for routine bedside use, with a score ≥8 indicating severe acute pancreatitis, and a score ≥6 having 95% sensitivity for detecting complications 7
• The APACHE-II score can be used for daily ongoing assessment to monitor disease progression or recovery, with demonstrated highest accuracy (AUC 0.88) for predicting severe acute pancreatitis in comparative studies 8

Traditional 48-Hour Scores

• A Ranson score ≥3 indicates severe disease, with sensitivity 75-87%, specificity 68-77.5%, and positive predictive value (PPV) 28.6-49% 9
• A Glasgow score ≥3 indicates severe disease, with sensitivity 61-71%, specificity 88-89%, and PPV 59-66% 9

Laboratory Markers

• Peak C-Reactive Protein (CRP) >210 mg/L in the first 4 days (or >120 mg/L at end of first week) indicates severe disease with ~80% accuracy, and CRP ≥150 mg/L on day 3 can be used as a prognostic factor 8

Radiological Assessment

• A CT Severity Index (CTSI) ≥3 indicates severe disease, with the CTSI scores 0-10 based on pancreatic inflammation grade and extent of necrosis, correlating with morbidity and mortality 7

Practical Clinical Algorithm

• Within 24 hours of admission, calculate BISAP score immediately, measure baseline CRP, and monitor for organ failure development, as the key advantage of BISAP is its ability to identify patients at increased risk of mortality prior to the onset of organ failure 8
• At 48 hours, consider calculating Ranson or Glasgow score if BISAP is equivocal, and use APACHE-II for ongoing daily monitoring in severe cases 9
• Days 3-10, perform contrast-enhanced CT with CTSI calculation in all patients with predicted severe disease, to assess pancreatic necrosis extent and peripancreatic fluid collections 8

Scoring Systems for Predicting Severity in Acute Pancreatitis

BISAP Score Performance

• The World Journal of Emergency Surgery reports that the BISAP score is one of the most accurate and practical bedside tools for acute pancreatitis, able to predict severity, mortality, and organ failure with an area under the receiver‑operating‑characteristic curve (AUC) of 0.80 for severe pancreatitis and 0.93 for organ failure, and it identifies patients at heightened risk of death before organ failure develops. 10

APACHE‑II Score Performance

• The same source indicates that APACHE‑II remains the gold‑standard scoring system for ongoing monitoring of acute pancreatitis, providing the highest predictive accuracy for mortality with an AUC ranging from 0.88 to 0.93 in comparative studies, although its complexity and the need for many routinely uncollected parameters limit its bedside practicality. 10

Limitations of APACHE II for Assessing Pancreatic Necrosis

Imaging Requirement

• APACHE II scoring does not reliably predict the extent of pancreatic necrosis; therefore, contrast‑enhanced computed tomography performed between days 3‑10 is required to assess necrosis accurately. 11

Acute Pancreatitis Severity Scoring: Evidence‑Based Recommendations

Ranson Scoring System

• The Ranson score comprises 11 clinical and laboratory parameters assessed over the first 48 hours of admission; a total of ≥ 3 points defines severe acute pancreatitis. 12
• In predicting severe disease, the Ranson score demonstrates a sensitivity of approximately 75‑87 % and a specificity of 68‑77.5 %.12
• Its positive predictive value is limited (≈ 28‑49 %), indicating that many patients classified as “severe” will recover without complications.12
• A major limitation is the mandatory 48‑hour interval before the score can be completed, which delays early risk stratification and may postpone necessary interventions.12
• All traditional 48‑hour scores (e.g., Ranson, Glasgow) share this delay, preventing admission‑time risk assessment.12

BISAP as Preferred Early Tool

• The American College of Surgeons (in conjunction with the World Journal of Emergency Surgery) recommends using the BISAP score instead of Ranson because it can be calculated within 24 hours and provides comparable or superior accuracy.12
• BISAP ≥ 2 is the critical cutoff for severe disease; it yields an area‑under‑the‑curve (AUC) of 0.80 for severe pancreatitis and 0.93 for predicting organ failure.12
• BISAP identifies patients at heightened mortality risk before organ failure develops, unlike the delayed Ranson assessment.12
• Comparative data show that BISAP predicts severity, death, and organ failure as well as APACHE‑II and more accurately than Ranson criteria.12

Alternative Scoring Systems (APACHE‑II)

• The APACHE‑II score, when ≥ 8, offers the highest predictive accuracy among available systems (AUC 0.88‑0.93).12

Imaging Guidance for Predicted Severe Cases

• For patients flagged as high‑risk by any early score (BISAP ≥ 2, Ranson ≥ 3, or APACHE‑II ≥ 8), a contrast‑enhanced CT scan with CT Severity Index (CTSI) calculation should be performed between days 3‑10 of illness.12

Antibiotic Stewardship

• Prophylactic antibiotics should not be initiated solely based on severity scores; this recommendation carries Grade 1A evidence.12
• In sterile pancreatic necrosis, prophylactic antibiotics provide no mortality or morbidity benefit.12
• Antibiotics should be reserved for cases with documented infected necrosis.12

Clinical Implications of Ranson’s Predictive Value

• Although a Ranson score ≥ 3 correlates with increased mortality risk, its modest positive predictive value means many patients meeting this threshold will recover uneventfully; clinicians must therefore combine scoring with real‑time clinical assessment.12